טוען...
Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication
Therapeutics targeting replication of SARS coronavirus 2 (SARS-CoV-2) are urgently needed. Coronaviruses rely on host membranes for entry, establishment of replication centers and egress. Compounds targeting cellular membrane biology and lipid biosynthetic pathways have previously shown promise as a...
שמור ב:
| הוצא לאור ב: | bioRxiv |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cold Spring Harbor Laboratory
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386504/ https://ncbi.nlm.nih.gov/pubmed/32743584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.18.210211 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|